CCL2 and cancer: Meanwhile, −2518A/G (rs1024611) is the most widely studied CCL2 regulatory SNP and has the most well-defined function in tumors; its G allele rs1024611G is associated with high CCL2 expression and poor clinical prognosis in a variety of cancers (41).